retatrutide ly3437943 glp-1 gip glucagon just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric retatrutide ly3437943 triple agonist glp-1
Description
Time stays the same
GLP-1RAs work with your body's natural GLP-1 receptors to regulate weight loss, and metabolic function, as well as decrease your risk of other diseases
COMMENTARY Why Is This Important
U.S.A 47 ValassiE.ScacchiM.CavagniniF
People may be able to pay for these out of pocket at a lower price than the injector pens
Clin Med (Lond) 2023;23:284291
